CD36 and metabolic dysfunction-associated steatotic liver disease: Moreover, it could be demonstrated that CD36 expression is upregulated in the livers of MASLD patients, leading to hepatic triglyceride accumulation and consequently an exacerbation of hepatic steatosis (Pei et al., 2020).